1. "Melanoma and Immunotherapeutics Service"
Formats
  1. Journal Article (954)
  2. Meeting Abstract (771)
  3. Book Section (42)
  4. Editorial (32)
  5. Review (26)
  6. Research Letter (15)
  7. Guidelines (6)
  8. Correspondence (5)
  9. Conference Paper (4)
  10. Miscellaneous (3)
  11. Book Whole (2)
Groups
  1. Department of Medicine (1860)
  2. Melanoma and Immunotherapeutics Service (1860)
  3. Solid Tumor Oncology Division (1860)
  4. GSK Faculty (1050)
  5. Melanoma Disease Management Team (782)
  6. Hematologic Malignancies, Division of (507)

More Groups

People
  1. Jedd Wolchok (905)
  2. Taha Merghoub (364)
  3. Michael Postow (361)
  4. Paul Chapman (326)
  5. Alexander Shoushtari (244)
  6. Margaret Callahan (197)

More People

Years
  1. 2025 (22)
  2. 2024 (46)
  3. 2023 (66)
  4. 2022 (125)
  5. 2021 (112)
  6. 2020 (122)

More Years

Publications
  1. Journal of Clinical Oncology (330)
  2. Journal for ImmunoTherapy of Cancer (131)
  3. Cancer Research (106)
  4. Clinical Cancer Research (90)
  5. Annals of Oncology (77)
  6. Proceedings of the American Association for Cancer Research Annual Meeting (43)

More Publications

Publishers
  1. American Society of Clinical Oncology (342)
  2. American Association for Cancer Research (274)
  3. Biomed Central Ltd (148)
  4. Elsevier Inc. (144)
  5. Oxford University Press (109)
  6. Nature Publishing Group (88)

More Publishers

Results (1860)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Neoadjuvant anti-PD1, nivolumab, in early stage resectable non-small-cell lung cancer
    Meeting Abstract

    Forde, P. M.; Smith, K.; Chaft, J. E.; Hellmann, M. D.; Merghoub, T.; Wolchok, J. D.; Yang, S. C.; Battafarano, R. J.; Gabrielson, E.; Georgiades, C.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Safety data from an expanded access program (EAP) of nivolumab (NIVO) in combination with ipilimumab (IPI) in patients with advanced melanoma (MEL)
    Meeting Abstract

    Chapman, P. B.; Sznol, M.; Lao, C.; Gonzalez, R.; Daniels, G. A.; Thompson, J. A.; Kudchadkar, R. R.; Sharfman, W. H.; Atkins, M. B.; Pavlick, A. C.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Neutrophil to lymphocyte ratio to predict outcome during ipilimumab treatment
    Meeting Abstract

    Cassidy, M. R.; Wolchok, R.; Zheng, J.; Panageas, K.; Wolchok, J. D.; Coit, D. G.; Postow, M. A.; Ariyan, C. E.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Appendiceal enlargement during immunotherapy treatment for melanoma
    Journal Article

    Bello, D. M.; Callahan, M. K.; Busam, K.; Ariyan, C. E.
    Clinical Skin Cancer (2016)

    Fulltext@MSK | Save
  • Genome-scale neoantigen screening using ATLAS™ prioritizes candidates for immunotherapy in a non-small cell lung cancer patient
    Meeting Abstract

    Ghamsari, L.; Flano, E.; Jacques, J.; Liu, B.; Havel, J.; Makarov, V.; Merghoub, T.; Wolchok, J. D.; Hellmann, M. D.; Chan, T. A.; more...
    Journal for ImmunoTherapy of Cancer (2016)

    Fulltext@MSK | Save
  • Intratumoral delivery of modified vaccinia virus Ankara expressing human flt3L as cancer immunotherapy
    Meeting Abstract

    Dai, P.; Wang, W.; Yang, N.; Shuman, S.; Merghoub, T.; Wolchok, J. D.; Deng, L.
    Journal for ImmunoTherapy of Cancer (2016)

    Fulltext@MSK | Save
  • Opposing effects of CTLA-4 and PD-1 blockade on follicular helperlike T cells with immunosuppressive functions
    Meeting Abstract

    Zappasodi, R.; Budhu, S.; Hellmann, M. D.; Postow, M.; Senbabaoglu, Y.; Gasmi, B.; Zhong, H.; Li, Y.; Liu, C.; Hirschhorhn-Cymerman, D.; more...
    Journal for ImmunoTherapy of Cancer (2016)

    Fulltext@MSK | Save
  • Initial experience administering BMS-986016, a monoclonal antibody that targets lymphocyte activation gene (LAG)-3, alone and in combination with nivolumab to patients with hematologic and solid malignancies
    Meeting Abstract

    Lipson, E.; Gopal, A.; Neelapu, S. S.; Armand, P.; Spurgeon, S.; Leonard, J. P.; Hodi, F. S.; Sanborn, R. E.; Melero, I.; Gajewski, T. F.; more...
    Journal for ImmunoTherapy of Cancer (2016)

    Fulltext@MSK | Save
  • Local intratumoral treatment with low-dose CD40 and TLR4 agonists overcomes resistance to PD-1 blockade to control tumors systemically
    Meeting Abstract

    Khalil, D. N.; Campesato, L. F.; Li, Y.; Merghoub, T.; Wolchok, J. D.
    Journal for ImmunoTherapy of Cancer (2016)

    Fulltext@MSK | Save
  • Phosphatidylserine targeting antibody in combination with checkpoint blockade and tumor radiation therapy promotes anticancer activity in mouse melanoma
    Meeting Abstract

    Budhu, S.; De Henau, O.; Zappasodi, R.; Schlunegger, K.; Freimark, B.; Hutchins, J.; Barker, C. A.; Wolchok, J. D.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2016)

    Fulltext@MSK | Save